SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Fund declared regular monthly distributions to shareholders across three share classes (Class S, D, and I) with specified per-share amounts ($0.16851, $0.18050, and $0.18550 respectively), payable on October 28, 2026.
View raw filing on EDGAR →The Oregon PUC issued a final order (No. 26-354) on PGE's holding company reorganization application that imposes conditions departing from the agreed stipulation, including restrictions on dividends and ordinary course business activities. The Company states it will not proceed with the reorganization unless these provisions are clarified or modified, and cannot estimate the full financial impact. This is a material regulatory decision affecting a major strategic initiative, but does not fit neatly into financial, legal, or governance categories—it is fundamentally an operational/strategic matter involving regulatory approval of a corporate restructuring.
View raw filing on EDGAR →CarMax Auto Funding LLC closed on September 28, 2026, the issuance of $600 million in aggregate principal amount of asset-backed notes (Class A-1, A-2, A-3, B, C, D, and E) pursuant to an Indenture with U.S. Bank Trust Company as indenture trustee. This constitutes creation of a new direct financial obligation through debt issuance, which is a material capital event for the registrant. The transaction involved multiple supporting agreements (Receivables Purchase Agreement, Sale and Servicing Agreement, Administration Agreement, etc.) establishing the securitization structure for motor vehicle retail installment sale contracts.
View raw filing on EDGAR →ADARx completed its IPO on September 28, 2026, issuing 26.25 million registered shares at $17.00 per share for approximately $446.3 million in gross proceeds, concurrent with a private placement of 5,255,542 unregistered shares to AbbVie Inc. at the same price for approximately $89.3 million. The combined equity issuance of approximately $535.6 million represents a material capital raise and significant dilution to existing shareholders.
View raw filing on EDGAR →The Trust issued 151,900 shares in private placement transactions to accredited investors pursuant to Rule 506(c) of Regulation D, exempt from Securities Act registration. The filing explicitly discloses unregistered equity sales totaling $891,272 in aggregate value, with Grayscale Securities acting as Authorized Participant and potential underwriter. This is a classic dilutive issuance under Item 3.02, material to investors as it increases share count and dilutes existing holders.
View raw filing on EDGAR →Dipti Vachani was appointed as Chief Executive Officer and Board member of Adeia Inc., effective October 12, 2026, succeeding Paul E. Davis who resigned. Vachani brings 30 years of semiconductor industry experience and will receive a base salary of $730,000 and an $11 million equity grant, with severance protections.
View raw filing on EDGAR →The Company failed to satisfy Nasdaq's minimum bid price requirement of $1.00 for 30 consecutive business days and was transferred from The Nasdaq Global Select Market to The Nasdaq Capital Market on September 24, 2026. The Company has been granted an additional 180-calendar day compliance period (until March 22, 2027) to regain compliance, with no assurance of success.
View raw filing on EDGAR →Michael J. Ragusa, Senior Vice President and Chief Accounting Officer (principal accounting officer), informed the Company on September 25, 2026 of his intention to resign effective November 1, 2026. Lee A. Boyce will assume the principal accounting officer role.
View raw filing on EDGAR →The Company announced a quarterly cash dividend of $0.10 per voting and non-voting common share, payable November 6, 2026 to shareholders of record on October 16, 2026. This is a routine but material dividend declaration that affects shareholder returns and is customarily disclosed in 8-K Item 8.01 filings by public companies.
View raw filing on EDGAR →Aditya J. Gandhi was appointed Vice President and Chief Accounting Officer of Graphic Packaging effective September 28, 2026. The disclosure centers on the appointment of a named executive officer to a senior financial role, with details on his background, compensation (restricted stock units valued at ~$715,000 vesting over three years and a $105,000 cash sign-on bonus), and reporting structure. This is a material executive appointment that would affect investor assessment of the company's financial leadership.
View raw filing on EDGAR →Cambium Networks completed the sale of its defense business and certain fixed broadband product lines to Airspan Communications Limited for US$27.5 million in cash plus contingent consideration up to US$7.5 million on September 22, 2026. The company expects to wind down operations and dissolve following the transaction, making this a terminal disposition materially affecting the registrant's existence and shareholder value.
View raw filing on EDGAR →Morgan Kurk resigned from the Board of Directors on September 24, 2026, though he retained his CEO position. The board departure is material to investors' assessment of governance and leadership continuity, particularly given the company's concurrent entry into administration and wind-down.
View raw filing on EDGAR →Kimberly Ernzen, Chief Operating Officer, is departing her role effective September 28, 2026. Although she will remain employed through December 31, 2026 to support the leadership transition, the principal disclosed action is her departure from the COO position. This is a material executive departure that would affect a reasonable investor's assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →Sabre Financial Borrower, LLC, an indirect wholly-owned subsidiary of Sabre Corporation, issued $1.35 billion in aggregate principal amount of 9.875% Senior Secured Notes due 2032 on September 28, 2026. The proceeds were used to refinance existing intercompany loans and repurchase outstanding notes as part of a comprehensive debt restructuring.
View raw filing on EDGAR →Viking Therapeutics entered into underwriting agreements for a $225 million convertible senior notes offering due 2032 (approximately $251 million net proceeds) and a concurrent equity offering of 7.9 million shares at $35 per share (approximately $297 million net proceeds), representing a combined material capital raise of approximately $548 million in gross proceeds.
View raw filing on EDGAR →Korn Ferry held its 2026 Annual Meeting of Stockholders and disclosed final voting results for the election of nine directors, approval of executive compensation, approval of an amended and restated stock incentive plan increasing available shares by 1.4 million and extending the plan term to 2036, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →Summit Therapeutics entered into a securities purchase agreement with AstraZeneca for a $2.0 billion private placement of 108,955.3686 shares of Class A Convertible Preferred Stock, convertible into common stock at a 1:1,000 ratio ($18.36 per share equivalent). The unregistered securities were issued under Section 4(a)(2) and Regulation D exemptions, with Summit agreeing to file a registration statement for resale of the underlying common shares.
View raw filing on EDGAR →On September 15, 2026, the Company granted 20,000,000 restricted Class A ordinary shares to certain employees under its 2026 Equity Incentive Plan "in consideration of services rendered." This is a material equity grant to employees, which constitutes executive or employee compensation disclosure under the equity-grant category. The grant is substantial in size (20 million shares) and represents a significant dilutive event affecting the cap table.
View raw filing on EDGAR →HUB Cyber Security received a Nasdaq deficiency notification on September 23, 2026, stating it is not in compliance with Nasdaq Listing Rule 5550(b)(2) requiring a minimum Market Value of Listed Securities (MVLS) of US$35 million. The Company has 180 calendar days until March 22, 2027 to regain compliance, or face delisting proceedings. This is a classic delisting-risk disclosure under Item 3.01 equivalent, materially affecting the registrant's continued listing status and investor assessment.
View raw filing on EDGAR →Flash Sports & Media Holdings' common stock was delisted from Nasdaq on September 25, 2026, and moved to OTC trading under symbol "FLZH". A Nasdaq continued listing hearing is scheduled for October 6, 2026, and the company has applied for OTCQB quotation, creating material uncertainty about the company's future listing status and market liquidity.
View raw filing on EDGAR →This is a press release announcing unaudited financial results for the six months ended June 30, 2026. The exhibit discloses revenue of US$14.31 million (up 94.4% YoY), gross profit of US$1.83 million (up 131.7% YoY), and net loss narrowed to US$3.32 million (down 56.8% YoY). The disclosure includes management commentary on the company's strategic shift from grocery to travel operations and forward-looking guidance on AI-enabled operations and China inbound tourism strategy. This is a material interim earnings announcement that would affect a reasonable investor's assessment of the registrant's financial performance and strategic direction.
View raw filing on EDGAR →The press release announces a binding term sheet between Psyence BioMed's wholly-owned subsidiary (TIRC) and PsyLabs granting exclusive U.S. development, supply, and distribution rights to pharmaceutical-grade ibogaine. This constitutes a material acquisition of exclusive rights and a strategic licensing arrangement with significant financial terms (up to $1.3M in milestone payments, annual exclusivity fees, and royalties on net sales). The transaction is binding and expected to be superseded by a definitive agreement by November 30, 2026, making it a material M&A-type activity that would affect a reasonable investor's assessment of the company's strategic position and future revenue potential.
View raw filing on EDGAR →This 6-K furnishes the registrant's financial results for the six months ended June 30, 2026, including condensed consolidated balance sheets, statements of operations, and comprehensive income. The filing explicitly states "furnishes under the cover of Form 6-K its financial results for the six months ended June 30, 2026" and includes full interim financial statements with comparative periods. This is a periodic interim financial report, not a discrete event or earnings press release.
View raw filing on EDGAR →This press release announces a material clinical development milestone: the first participants dosed in the Phase 2a BANYAN clinical trial of intranasal foralumab for ALS. The disclosure describes trial design, enrollment criteria, endpoints, and investigator details. This represents a significant operational and strategic advancement for Tiziana's lead development candidate, affecting investor assessment of pipeline progress and clinical execution capability. While not a discrete event type like M&A or exec change, it is clearly material operational progress in drug development.
View raw filing on EDGAR →Pasqal announces a strategic shift in its collaboration with French public authorities: termination of participation in the defense program LSQUARE (PROQCIMA) and redirection toward civil public support programs focused on fault-tolerant quantum computing. This represents a material operational and strategic pivot affecting the company's R&D roadmap and government relationships, though it does not fit neatly into a specific event category (not M&A, not a discrete contract, not a workforce action). The shift is material because it affects the company's strategic direction and funding sources, but the domain is clearly operational rather than financial, governance, or legal.
View raw filing on EDGAR →The filing discloses a jury verdict in a material insurance coverage litigation case. On September 25, 2026, a federal jury awarded Ramaco LLC $30.0 million in damages ($2.5 million for aggravation and inconvenience, $27.5 million for net economic loss) against Federal Insurance Company and ACE American Insurance Company in connection with a wrongful denial of an insurance claim arising from a 2018 silo collapse. This is a significant litigation outcome with substantial financial consequences that would materially affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →The 6-K discloses completion of a shareholder-approved share capital reorganization (reduction of par value from US$0.32 to US$0.0001 per share) and adoption of an eighth amended and restated memorandum and articles of association to reflect this reorganization. This is a governance event involving fundamental changes to the company's capital structure and constitutional documents, approved at an extraordinary general meeting on September 15, 2026, and completed following Cayman Islands regulatory registration. While primarily administrative in nature, the par value reduction is material to shareholders as it affects the company's authorized capital structure and potential future equity issuances.
View raw filing on EDGAR →This press release announces the launch of two new products—the AI Token Platform and AI Apps—at Tech Week Singapore 2026. The disclosure describes new product capabilities and market positioning that extend SuperX's portfolio from AI infrastructure into model access and application workflows. This is a material operational/strategic event (product launch) that would affect a reasonable investor's assessment of the company's business direction and competitive positioning, though it does not fit the specific categories of earnings, M&A, executive changes, or other named event types.
View raw filing on EDGAR →Bold Eagle Acquisition Corp. (a SPAC) entered into a definitive Business Combination Agreement with REDLattice, valuing REDLattice at $1.25 billion enterprise value. The transaction involves domestication of Bold Eagle from Cayman Islands to Delaware, followed by a merger resulting in REDLattice as a wholly-owned subsidiary of the resulting public company, with approximately $610 million in gross proceeds and expected close around year-end 2026 subject to shareholder approval.
View raw filing on EDGAR →In connection with the business combination, Bold Eagle is issuing unregistered equity securities including PubCo Common Stock, PIPE Shares, Convertible Notes, and Underlying Shares pursuant to Subscription Agreements, representing $335 million of committed capital ($275 million in convertible notes and $60 million in common stock PIPE), all relying on Section 4(a)(2) exemption.
View raw filing on EDGAR →This press release announces the planned effectiveness of a cross-border merger and redomiciliation of WISeKey from Switzerland to the British Virgin Islands, with WISeKey being absorbed into its wholly owned BVI subsidiary WISeQey Corp. The merger was approved by shareholders on September 9, 2026, and is expected to become effective on October 2, 2026. This constitutes a material change of control and corporate restructuring that would affect investor assessment of the registrant's legal domicile, listing status (ticker change from WKEY to WQEY), and corporate structure, even though operations remain substantially unchanged.
View raw filing on EDGAR →This Item 1.01 discloses entry into Amendment No. 3 to a Business Combination Agreement dated September 26, 2026, between SVAQ, Merger Sub, and EigenQ. The amendment modifies warrant treatment and clarifies exchange mechanics for the proposed business combination. While the amendment itself is technical in nature (excluding certain warrants from definitions and clarifying warrant exchange), it is part of a material acquisition/change-of-control transaction—the merger of EigenQ into SVAQ's subsidiary with EigenQ continuing as the surviving company. The filing explicitly states this is a material definitive agreement under Item 1.01, and the business combination itself is clearly material to investors.
View raw filing on EDGAR →Powell Max Limited has signed a share exchange agreement with Blackrod Holdings, LLC (parent of Remington Firearms), acquiring an initial minority stake and securing an exclusive 12-month period to negotiate acquisition of remaining ownership interests, establishing a defined path to majority control of a major firearms brand.
View raw filing on EDGAR →Investor presentation disclosing Blackrod Holdings, LLC's business model for manufacturing Remington-branded firearms, management team, brand heritage, and forward-looking financial projections for 2026–2028, providing strategic and operational context for the company's firearms manufacturing operations.
View raw filing on EDGAR →The 6-K discloses the results of an Extraordinary General Meeting of Shareholders held on September 22, 2026, where shareholders voted on and approved a share consolidation resolution (40-for-1 consolidation). The filing presents voting tallies (67,997,978 votes for, 274,430 against, 7,322 abstain) representing 90.68% of exercisable votes, which is a direct disclosure of shareholder vote results under Item 5.07 equivalent. The share consolidation is a material capital structure change requiring shareholder approval.
View raw filing on EDGAR →The 6-K discloses entry into a securities purchase agreement on September 28, 2026, for the issuance of 11,750,072 ordinary shares at US$1.27 per share, generating gross proceeds of approximately US$14.9 million. The shares are being offered to non-U.S. persons in reliance on Regulation S and have not been registered under the Securities Act, making this an unregistered private placement — a classic dilutive issuance. The magnitude (11.75 million shares) and capital raised (US$14.9 million) are material to a reasonable investor's assessment of the registrant's capitalization and ownership structure.
View raw filing on EDGAR →The filing discloses the adjournment of an Extraordinary General Meeting of shareholders scheduled to vote on a proposed business combination with WISeSat.Space Corp. While technically an adjournment rather than vote results, this is a material shareholder meeting event under Item 8.01 that directly impacts the timing and conduct of a shareholder vote on a material M&A transaction. The meeting was reconvened on September 28, 2026 and adjourned again to September 29, 2026 without conducting business, which is a significant governance event affecting shareholder voting rights on the proposed business combination.
View raw filing on EDGAR →Proem Acquisition Corp. I (SPAC) entered into a definitive merger agreement with Astro Digital US, Inc., a material business combination with an enterprise value of approximately $587 million, funded by $130 million from Proem's trust account and $50 million in PIPE investments, with anticipated closing in Q1 2027 and subject to shareholder approval.
View raw filing on EDGAR →Proem issued approximately $50 million in unregistered Parent Common Shares to PIPE investors pursuant to PIPE Subscription Agreements, relying on Section 4(a)(2) and Regulation D exemptions, with Proem Asset Management and affiliates committing $25 million of the total.
View raw filing on EDGAR →This press release announces an underwritten registered direct offering of 833,334 ordinary shares at $0.60 per share and pre-funded warrants to purchase 24,166,666 ordinary shares at $0.5999 per share, raising approximately $15 million in gross proceeds. The offering involves registered securities sold directly to investors, which is a classic dilutive equity issuance. The company explicitly states the offering is being made pursuant to an effective Form F-3 registration statement, and the securities are being offered to the public, making this a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.
View raw filing on EDGAR →The 6-K discloses that Datasea received a Nasdaq staff determination notice on March 27, 2026, for failure to maintain the $1 minimum bid price requirement. Although initially granted a 180-day compliance period until September 23, 2026, the Company was granted an additional 180-day extension on September 24, 2026, until March 22, 2027. The filing explicitly states that if the Company does not regain compliance by the Compliance Date, "Nasdaq will provide written notification that the Company's securities are subject to delisting." This is a material delisting risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →The press release announces a private placement of 667,000 Class A ordinary shares at US$1.50 per share for aggregate gross proceeds of approximately US$1.0 million, plus Series A and Series B warrants for no additional consideration. This is an unregistered sale of equity securities in reliance on exemptions from registration under the Securities Act of 1933, which is a classic dilutive issuance. The transaction is material as it raises capital and dilutes existing shareholders' ownership stakes.
View raw filing on EDGAR →The press release announces the closing of a public offering of 12,000,000 Class A ordinary shares at $0.80 per share, generating approximately $9,600,000 in gross proceeds. This is a registered follow-on public offering (Form F-1) that dilutes existing shareholders. The offering is material to investors as it represents a significant capital raise and equity dilution event.
View raw filing on EDGAR →The 6-K discloses completion of three material acquisition transactions in September 2026: (1) acquisition of 100% equity in Qingdao Xingongguan for $5.8M via VIE agreements; (2) acquisition of assets from Zhaodong Guohe for $21.2M; and (3) acquisition of 33.33% equity in Qingdao Quanao for $25M. These transactions aggregate approximately $52M in purchase consideration and involve issuance of billions of Class A ordinary shares, directly addressing a Nasdaq listing compliance issue regarding minimum stockholders' equity of $2.5M.
View raw filing on EDGAR →The letter discloses a deficiency notification from Nasdaq on March 17, 2026, stating that the Company's closing bid price fell below the $1.00 minimum requirement for 30 consecutive business days, triggering Nasdaq Listing Rule 5550(a)(2). The letter explicitly acknowledges "the risk of delisting" and notes that "options available to rectify this problem...are not guaranteed." This is a material delisting-risk disclosure that would significantly affect investor assessment.
View raw filing on EDGAR →Tempest appointed Nancy Freda-Smith as a Class III director and Audit Committee Chair, and Constance Ames as Chief Financial Officer, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary on September 22, 2026, as part of board reconstitution efforts to regain Nasdaq compliance.
View raw filing on EDGAR →Tempest entered into a Master Services Agreement with Factor Bioscience Inc. on September 22, 2026, establishing terms for R&D services supporting CAR-T therapy development at an expected cost of $5.0 million annually, with Audit Committee approval reflecting the related-party nature of the transaction.
View raw filing on EDGAR →The filing discloses two governance events under Item 5.02: (1) removal of Seth Farbman from three board committees while retaining his director seat, and (2) appointment of Kenneth C. Greenberg as a new Class II director with committee assignments including Compensation Committee Chair. While the appointment of a new director with significant M&A and operational experience could be material to investors assessing board composition and governance, the primary disclosed action is a governance restructuring rather than a specific executive departure or appointment of an officer. The transfer of 11,667 Class B shares to Greenberg is incidental to the appointment. This is classified as governance_other because it involves board composition and committee structure changes that do not fit neatly into exec_departure or exec_appointment (which typically apply to C-suite officers), though the appointment of a new independent director with substantial experience is material to governance quality.
View raw filing on EDGAR →TOYO disclosed its second-half 2026 business outlook in response to a dynamic U.S. trade and regulatory environment, including CBP examination, CVD investigation, and Section 232 trade policy actions. While declining to provide specific financial guidance due to regulatory uncertainty, the company affirmed confidence in positive EBITDA, highlighting material trade and regulatory headwinds affecting its solar manufacturing business.
View raw filing on EDGAR →TOYO announced approximately $240 million in binding solar module supply agreements with multiple U.S. customers through H1 2027, covering utility-scale, commercial, industrial, community solar, and data-center applications. This represents a material commercial milestone demonstrating conversion of manufacturing capacity into contracted business and revenue visibility.
View raw filing on EDGAR →